Description
Your doctor may prescribe iron replacement to treat anemia, which is when a person has a lower-than-normal level of blood cells. Monoferric is an intravenous iron replacement therapy indicated to treat iron deficiency anemia in adult patients who have tried and failed other therapies.
Many iron infusion options are available, and your healthcare provider will make a personalized selection based on your specific needs. A distinctive feature of Monoferric is its ferric derisomaltose complex, which helps optimize iron delivery while minimizing the risk of hypersensitivity reactions.
Monoferric is administered through intravenous infusion, bypassing certain limitations of taking iron orally. Typically, Monoferric is prescribed for those who have faced challenges with oral therapy and exhibit non-hemodialysis-dependent chronic kidney disease.
Fact Table |
Formula |
FeO3(OH)x(C6H10O5)y |
License |
US FDA, EMA |
Bioavailability |
100% (intravenous) |
Legal status |
Prescription only (?) |
Chemical Name |
Ferric hydroxide, Oligo-isomaltoside complex |
Elimination half-life |
20-30 hours |
Dosage (Strength) |
100 mg/mL (available in 500 mg/5 mL vials) |
Pregnancy |
Use with caution |
Brands |
Monoferric |
Protein binding |
N/A (iron is bound to transferrin) |
PubChem CID |
127850142 |
MedlinePlus |
a619027 |
ChEBI |
CHEBI:134722 |
ATC code |
B03AC |
DrugBank |
DB14022 |
KEGG |
D10819 |
Routes of administration |
Intravenous |
Directions
Monoferric is administered through intravenous injection by healthcare professionals working within an infusion suite.
The standard dosage per infusion for patients weighing 50 kg and above is 1000 mg. Individuals weighing less than 50 kg will have their dosage determined by their healthcare team.
Ingredients
The active ingredient in Monoferric is ferric derisomaltose.
Interactions
The most common drug-drug interactions with this drug include:
- Baloxavir Marboxil
- Bictegravir
- Carbidopa
- Cefdinir
- Ciprofloxacin
- Delafloxacin
- Demeclocycline
- Dimercaprol
- Dolutegravir
- Doxycycline
- Eltrombopag
- Elvitegravir
- Ethinyl Estradiol
- Gatifloxacin
- Grepafloxacin
- Levodopa
- Levofloxacin
- Levothyroxine
- Lomefloxacin
- Magnesium Sulfate
- Methyldopa
- Minocycline
- Moxifloxacin
- Mycophenolate Mofetil
- Mycophenolic Acid
- Norfloxacin
- Ofloxacin
- Omadacycline
- Omeprazole
- Penicillamine
- Raltegravir
- Temafloxacin
- Tetracycline
- Trovafloxacin Mesylate
- Zinc
Cautions
Tell your doctor if you have a history of allergic reactions to iron products before starting this drug.
During treatment, your doctor and healthcare team should monitor for hypersensitivity reactions, such as rashes or breathing difficulties.
Tell your doctor if you have a history of inflammatory disorders or chronic infections before starting Monoferric therapy.
Side Effects
Common side effects may include:
- Hypersensitivity
- Hypophosphatemia
- Iron overload
- Nausea
- Rash
References
- Monoferric [package insert]. Holbaek, Denmark: Pharmacosmos A/S; January 2010.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14578